α-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression

Laboratory Investigation

Volumn 87, Issue 9, 2007, Pages 938-950

  Yuan, Kaiyu ^a   Chung, Leland W K ^b   Siegal, Gene P ^c   Zayzafoon, Majd ^a  

^a University of Alabama at Birmingham   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

CaMKII; Cell cycle; Osteoblasts; Osteosarcoma; p21; Rac1

Indexed keywords

PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN P21; RAC1 PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; SOLID TUMOR; TRANSACTIVATION;

ANIMALS; BENZYLAMINES; BONE NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE; CELL LINE, TUMOR; HUMANS; MALE; MICE; OSTEOSARCOMA; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 34547933870     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700658     Document Type: Article

References (53)

1. Papachristou DJ, Batistatou A, Sykiotis GP, et al. Activation of the JNKAP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003;32:364-371.
2. Dahlin DC, Unni KK. Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol 1977;1:61-72.
3. Ballance Jr WA, Mendelsohn G, Carter JR, et al. Osteogenic sarcoma. Malignant fibrous histiocytoma subtype. Cancer 1988;62:763-771.
4. Unni KK. Osteosarcoma of bone. J Orthop Sci 1998;3:287-294.
5. Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 2006;125:555-581.
6. Pestell RG, Albanese C, Reutens AT, et al. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999;20:501-534.
7. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
8. Zhang CL, Liao WM, Li FB, et al. Prognostic significance of p21(WAF1) expression in osteosarcoma. Zhonghua Bing Li Xue Za Zhi 2005;34:524-527.
9. Agiostratidou G, Derventzi A, Gonos ES. Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines. In Vivo 2001;15:443-446.
10. Zayzafoon M, Fulzele K, McDonald JM. Calmodulin and calmodulindependent kinase II{alpha} Regulate osteoblast differentiation by controlling c-fos expression. J Biol Chem 2005;280:7049-7059.
11. Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 2006;97:56-70.
12. Deb TB, Coticchia CM, Dickson RB. Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells. J Biol Chem 2004;279:38903-38911.
13. Morris TA, DeLorenzo RJ, Tombes RM. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Exp Cell Res 1998;240:218-227.
14. Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997;11:2295-2322.
15. Gosens R, Schaafsma D, Nelemans SA, et al. Rho-kinase as a drug target for the treatment of airway hyperresponsiveness in asthma. Mini Rev Med Chem 2006;6:339-348.
16. Buchanan FG, Elliot CM, Gibbs M, et al. Translocation of the Rac1 guanine nucleotide exchange factor Tiam1 induced by platelet-derived growth factor and lysophosphatidic acid. J Biol Chem 2000;275:9742-9748.
17. Fleming IN, Elliott CM, Buchanan FG, et al. Ca2+/calmodulin- dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation. J Biol Chem 1999;274:12753-12758.
18. Michiels F, Stam JC, Hordijk PL, et al. Regulated membrane localization of Tiam1, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and C-Jun NH2-terminal kinase activation. J Cell Biol 1997;137:387-398.
19. Bourguignon LY, Zhu H, Shao L, et al. Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J Cell Biol 2000;150:177-191.
20. Bourguignon LY, Zhu H, Shao L, et al. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem 2000;275:1829-1838.
21. Cavazzin C, Bonvicini C, Nocera A, et al. Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts. Neurobiol Aging 2004;25:1187-1196.
22. Zayzafoon M, Gathings WE, McDonald JM. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology 2004;145:2421-2432.
23. Ohta M, Tateishi K, Kanai F, et al. p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 2005;65:10822-10829.
24. Bindra RS, Gibson SL, Meng A, et al. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 2005;65:11597-11604.
25. Xiao C, Yang BF, Song JH, et al. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Exp Cell Res 2005;304:244-255.
26. Sasaki A, Boyce BF, Story B, et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 1995;55:3551-3557.
27. Yu Y, Harris RI, Yang JL, et al. Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines. J Biomed Mater Res 2004;70A:122-128.
28. Huang WC, Wu D, Xie Z, et al. {beta} 2-Microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 2006;66:9108-9116.
29. Zayzafoon M, Abdulkadir SA, McDonald JM. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. J Biol Chem 2004;279:3662-3670.
30. Baitinger C, Alderton J, Poenie M, et al. Multifunctional Ca2+/ calmodulin-dependent protein kinase is necessary for nuclear envelope breakdown. J Cell Biol 1990;111:1763-1773.
31. Juang YT, Wang Y, Solomou EE, et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest 2005;115:996-1005.
32. Madgwick S, Levasseur M, Jones KT. Calmodulin-dependent protein kinase II, and not protein kinase C, is sufficient for triggering cell-cycle resumption in mammalian eggs. J Cell Sci 2005;118:3849-3859.
33. Pompetti F, Rizzo P, Simon RM, et al. Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 1996;63:37-50.
34. Nielsen GP, Burns KL, Rosenberg AE, et al. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Am J Pathol 1998;153:159-163.
35. Tombes RM, Krystal GW. Identification of novel human tumor cellspecific CaMK-II variants. Biochim Biophys Acta 1997;1355:281-292.
36. Hunt DA, Lane HM, Zygmont ME, et al. MRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines. Anticancer Res 2007;27:27-34.
37. Agoston AT, Argani P, Yegnasubramanian S, et al. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J Biol Chem 2005;280:18302-18310.
38. Sun HL, Liu YN, Huang YT, et al. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 2007;26:3941-3951.
39. Barry EL, Gesek FA, Froehner SC, et al. Multiple calcium channel transcripts in rat osteosarcoma cells: selective activation of alpha 1D isoform by parathyroid hormone. Proc Natl Acad Sci USA 1995;92:10914-10918.
40. Whitfield JF. Calcium signals and cancer. Crit Rev Oncog 1992;3:55-90.
41. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/ calmodulin-dependent pathways. Endocr Rev 2003;24:719-736.
42. Rodriguez-Mora OG, LaHair MM, McCubrey JA, et al. Calcium/ calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res 2005;65:5408-5416.
43. Kahl CR, Means AR. Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I. J Biol Chem 2004;279:15411-15419.
44. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005;65:3980-3985.
45. Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
46. Zhang H, Hannon GJ, Casso D, et al. p21 is a component of active cell cycle kinases. Cold Spring Harb Symp Quant Biol 1994;59:21-29.
47. He G, Siddik ZH, Huang Z, et al. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 2005;24:2929-2943.
48. Munoz-Alonso MJ, Acosta JC, Richard C, et al. p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem 2005;280:18120-18129.
49. Uchibori M, Nishida Y, Nagasaka T, et al. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol 2006;28:33-42.
50. Quinn CO, Rajakumar RA, Agapova OA. Parathyroid hormone induces rat interstitial collagenase mRNA through Ets-1 facilitated by cyclic AMP response element-binding protein and Ca(2+)/calmodulin-dependent protein kinase II in osteoblastic cells. J Mol Endocrinol 2000;25:73-84.
51. Gjoerup O, Lukas J, Bartek J, et al. Rac and Cdc42 are potent stimulators of E2F-dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation. J Biol Chem 1998;273:18812-18818.
52. Knight-Krajewski S, Welsh CF, Liu Y, et al. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells. Oncogene 2004;23:5513-5522.
53. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33:891-895.